BioPharma Drug Approval

China NMPA Approves MicuRx's Contezolid for Treatment of Drug-Resistant Bacterial Infection

By leveraging the proprietary technology platform built for drug discovery and screening, MicuRx R&D team discovered the next-generation oxazolidinone ...

 June 04, 2021 | News

Govt.Of India finalises advance arrangement for Second Made in India Vaccine

Union Ministry of Health finalises advance arrangement with M/s Biological-E Ltd., Hyderabad for 30 cr COVID19 Vaccine doses The COVID-19 vaccine of Biolo...

 June 03, 2021 | News

Cognoa Receives FDA Marketing Authorization for Autism Diagnosis Aid

 – Cognoa, a pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with behavioral health...

 June 03, 2021 | News

Mycovia Pharmaceuticals Submits New Drug Application to the U.S. FDA

Also known as chronic yeast infection, RVVC is a debilitating infectious condition defined as three or more episodes per year. Although RVVC affects nearly...

 June 02, 2021 | News

Henlius Received IND Approval for Its Novel Anti-CD73 mAb HLX23 from US FDA

Currently, there is no CD73 targeted product on the market around the globe. A number of early clinical studies have shown reliable safety in monotherapy o...

 June 01, 2021 | News

Henlius Received IND Approval for Its Novel Anti-CD73 mAb HLX23 from US FDA

Currently, there is no CD73 targeted product on the market around the globe. A number of early clinical studies have shown reliable safety in monotherapy o...

 June 01, 2021 | News

COMIRNATY® is the first to have its CMA extended to adolescents in Europe

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the Conditional Marketing Authorization (CMA) for COMIRNATY®...

 May 31, 2021 | News

FDA Approves Amgen LUMAKRAS™

KRAS G12C, a Driver Mutation Found in About 13% of Patients With Non-Squamous Non-Small Cell Lung Cancer, is Now Actionable(1) Once-Daily Dosing of LUMAKR...

 May 30, 2021 | News

Gannex Received China IND Approval

Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of non-...

 May 28, 2021 | News

Moderna and South Korea Explore Collaboration on mRNA Vaccines

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced two Memoranda of Unde...

 May 24, 2021 | News

Antengene Announces the IND Approval for Eltanexor

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commerc...

 May 14, 2021 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close